Latest open access TB research publications
Projected health and economic effects of a pan-tuberculosis
treatment regimen: a modelling study
The Lancet Global Health
16 August 2024 /open access/
--
Accompanying comment:
The potential distraction of a pan-regimen
approach to tuberculosis
/open access/
**************
Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for
drug-sensitive and drug-resistant pulmonary
tuberculosis treatment: a phase 2c, open-label,
multicentre, partially randomised controlled
trial
The Lancet Infectious Diseases
September 2024 /open access/
--
Accompanying comment:
A bedaquiline, pretomanid, moxifloxacin, and
pyrazinamide regimen for drug-susceptible and
drug-resistant tuberculosis
/open access/
**************
Global, regional, and national burden of HIV-negative
tuberculosis, 1990–2021: findings from the Global
Burden of Disease Study 2021
Infectious Diseases of Poverty
19 August 2024
/open access/
**************
Epidemiological features and temporal trends of the
co-infection between HIV and tuberculosis, 1990–2021:
findings from the Global Burden of Disease Study 2021
Infectious Diseases of Poverty
16 August 2024
/open access/
**************
Nationwide surveys of awareness of tuberculosis in India
uncover a gender gap in tuberculosis awareness
Communications Medicine
23 August 2024
/open access/
**************
The performance of digital technologies for measuring
tuberculosis medication adherence: a systematic review
BMJ Global Health
16 July 2024
/open access/
**************
Safety of a controlled human infection model of
tuberculosis with aerosolised, live-attenuated Mycobacterium
bovis BCG versus intradermal BCG in BCG-naive adults in the
UK: a dose-escalation, randomised, controlled, phase 1
trial
The Lancet Infectious Diseases
August 2024 /open access/
--
Accompanying comment:
A new tool for accelerating tuberculosis vaccine
development
/open access/
**************
Association between HIV and acquisition of rifamycin
resistance with first-line TB treatment: a systematic review
and meta-analysis
BMC Infectious Diseases
1 July 2024
/open access/
**************
Beyond the diagnosis of drug-resistant Tuberculosis in
Norway: patients’ experiences before, during and after
treatment
BMC Public Health
6 July 2024
/open access/
**************
Trends in the availability and prices of quality-assured
tuberculosis drugs: a systematic analysis of Global Drug
Facility Product Catalogs from 2001 to 2024
Globalization and Health
25 June 2024
/open access/
**************
